Precision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing therapeutics, the ultimate success of patient-data driven precision therapies hinges on three main factors: the quality of the tissue samples, the associated molecular data, and the analysis used in their development.
Gearing up on NANO: Pharmatech for nanodrugs
Sponsored PublicationsManufacturing of COVID vaccines showed that large-scale production of lipid nanoparticles (LNPs) as a delivery vehicle for mRNA vaccines is already possible. As nanocarrier-based formulations became mainstream, however, insufficiencies in existing technologies for routine GMP manufacturing became apparent. LEON is committed to bridging these technology gaps through its unique FR-JET technology and innovative manufacturing equipment.
Agomab Therapeutics NV raises US$100m in Series C financing
Latest NewsBelgian fibrosis specialist Agomab Therapeutics NV has raised US$100m to advance development of its pipeline.
Strengthening for start-up
AppointmentsThe Swedish start-up AAX Biotech welcomed Maria Lisa Knudsen as its new Managing Director at the end of September.
AstronauTx closes £48m Series A financing
Latest NewsAlzheimer’s specialist AstronauTx Ltd has closed a £48m Series A financing to create new treatments for Alzheimer’s diseas
Sino Biological Announces the Opening of its New US-Based Center for Bioprocessing
Sponsored PublicationsSino Biological, Inc., is pleased to announce the formal opening of its new Center for Bioprocessing (C4B) in Houston, Texas USA, adjacent to the world-renowned Texas Medical Center.
French team BioAroma awarded with BISC-E 2023 prize
Latest NewsAt the celebration of the 10th anniversary of the Bio-based Industry Consortium (BIC), the student team BioAroma was presented with the BISC-E 2023 award, which comes with €5000 in prize money.
Breakthrough in microtia treatment
Latest NewsResearchers developed an innovative ear transplant method to treat microtia using tissue-engineered human skin and bioprinted cartilage.
Orakl Oncology SA raises €3m to advance tumour modelling
Latest NewsParis-based Orakl Oncology SA has raised €3m to develop its techbio platform for precision oncology.
Precision therapeutics: optimising early discovery
BackgroundPrecision medicine tailors therapeutics to individual patients’ diseases, and is seen as the future of clinical practice. With significant time and financial investments being made in developing therapeutics, the ultimate success of patient-data driven precision therapies hinges on three main factors: the quality of the tissue samples, the associated molecular data, and the analysis used in their development.
BioM drives innovation in biotech
Sponsored PublicationsFor 25 years now, BioM has been the network organisation of the biotechnology sector in Munich and Bavaria. To shape the future of biotechnology, BioM identifies relevant and sustainable local, regional and global trends and creates a unique ecosystem for innovation and growth.